These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2113400)

  • 1. Aspects of growth hormone control in diabetes.
    Hyer SL; Kohner EM
    Aust N Z J Ophthalmol; 1990 Feb; 18(1):33-9. PubMed ID: 2113400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy.
    Pietschmann P; Schernthaner G; Prskavec F; Gisinger C; Freyler H
    Diabetes; 1987 Feb; 36(2):159-62. PubMed ID: 3100367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies?
    Harvey S; Martinez-Moreno CG
    Growth Horm IGF Res; 2016 Aug; 29():28-32. PubMed ID: 27082451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
    Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
    Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic retinopathy and growth hormone secretion in 39 non insulin-dependant diabetic patients].
    Hautecouverture M; Monchi A; Tchobroutsky G; Assan R; Slama G; Derot M
    Nouv Presse Med; 1973 Jul; 2(27):1817-22. PubMed ID: 4719844
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of human growth hormone secretion and its disorders.
    Kato Y; Murakami Y; Sohmiya M; Nishiki M
    Intern Med; 2002 Jan; 41(1):7-13. PubMed ID: 11838603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus.
    Krassowski J; Felber JP; Rogala H; Jeske W; Zgliczynski S
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):225-9. PubMed ID: 3132790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocrine abnormalities in diabetes mellitus].
    Takeda R; Nakagawa A; Nakabayashi H
    Nihon Rinsho; 1990 Dec; 48 Suppl():731-7. PubMed ID: 1964981
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1.
    Doi T; Striker LJ; Quaife C; Conti FG; Palmiter R; Behringer R; Brinster R; Striker GE
    Am J Pathol; 1988 Jun; 131(3):398-403. PubMed ID: 3132856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of immunoreactive insulin and human growth hormone release by administration of arginine in patients with diabetic retinopathy.
    Waldhäusl W
    Acta Endocrinol (Copenh); 1972 Aug; 70(4):719-30. PubMed ID: 5068400
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?
    Sönksen PH; Russell-Jones D; Jones RH
    Horm Res; 1993; 40(1-3):68-79. PubMed ID: 8300053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative retinopathy with growth hormone deficiency and diabetes mellitus.
    Quin JD; MacCuish AC; Gordon D
    BMJ; 1990 Jun; 300(6739):1586-7. PubMed ID: 2372634
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone in type I diabetic and healthy man.
    Schaper NC
    Acta Endocrinol (Copenh); 1990; 122 Suppl 2():1-47. PubMed ID: 2110412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
    Mauras N; Merimee T; Rogol AD
    Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth hormone secretion and nutrition].
    de Lemos Silva GM; Tirapegui J
    Arq Gastroenterol; 1994; 31(4):159-72. PubMed ID: 7575177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin stimulates growth hormone release from the pituitary via hypothalamic growth hormone-releasing hormone neurons in the cichlid, Oreochromis niloticus.
    Ogawa S; Liu X; Shepherd BS; Parhar IS
    Cell Tissue Res; 2018 Nov; 374(2):349-365. PubMed ID: 29934855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
    Bruni B; Bruni-Bocher K; Della Valle A; Gamba S
    Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine Modulates the Hormones of the Growth Hormone/Insulinlike Growth Factor-1 Axis During Development in Mice.
    Lecomte MJ; Bertolus C; Ramanantsoa N; Saurini F; Callebert J; Sénamaud-Beaufort C; Ringot M; Bourgeois T; Matrot B; Collet C; Nardelli J; Mallet J; Vodjdani G; Gallego J; Launay JM; Berrard S
    Endocrinology; 2018 Apr; 159(4):1844-1859. PubMed ID: 29509880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.